z-logo
open-access-imgOpen Access
FP499PHARMACODYNAMIC REASON WHY THE DOSE OF SGLT2 INHIBITORS SHOULD NOT BE REDUCED IN PATIENTS WITH GFR LESS THAN 45 ML/MIN
Author(s) -
Frieder Keller
Publication year - 2019
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfz106.fp499
Subject(s) - medicine , urology , renal function , pharmacology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom